Delivery Order SPE2DB22D3016-SPE2DB25FAMP2
Award Date
2/6/25
Potential Completion Date
2/7/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,562.50 firm fixed-price delivery order is for ONTRUZANT 150 MG VIALS, a medical product, with a completion date of December 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $17,781.12 fixed-price contract is for the supply of ONTRUZANT 420 MG VIALS, a specialty medication. The contract has an ultimate completion date of October 30, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $45,833.56, is for the supply of ONTRUZANT 150 MG VIALS, a specialty pharmaceutical product. The contract has a ceiling value of $45,833.56 and an ultimate completion date of September 10, 2024. It is a firm-fixed-price delivery order contract, and no set-aside designation was used. Amerisourcebergen,...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution and services company. The contract is for the delivery of 150 mg vials of the pharmaceutical product ONTRUZANT, with a ceiling value of $16,458.59 and a completion date of April 9, 2024. AmerisourceBergen Drug Corp is the prime contractor for this award,...
The Defense Logistics Agency (DLA) awarded a $26,724.31 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 420 mg vials of the drug ONTRUZANT. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, in support of military treatment...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ontruzant 150 mg vials. The $8,445.78 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military and veteran healthcare programs. The contract has an ultimate completion date of December 10, 2024 and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999...
The federal contract award SPE2DX15D1022|SPE2DX25FVBPF, valued at $5,468.75, was granted to the prime contractor Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $14,060.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ONTRUZANT 420 MG VIALS to be delivered by January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract falls under a larger indefinite delivery contract (IDC) awarded solely to...
This federal contract award, with an ID of SPE2DB22D3016|SPE2DB24FAZD9, is for the delivery of ONTRUZANT 150 MG VIALS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024, with a ceiling value of $8,080.33. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $78,114.24, is for the delivery of KEYTRUDA 100 MG/4 ML VIAL 4ML, a critical pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...